Theranostics Health Announces Expanded Breadth and Utility of TheraLink® Assay for Breast Cancer

Theranostics Health, Inc., announced today the launch of a greatly enhanced TheraLink® Assay Panel for Breast Cancer that incorporates several improvements in its ability to identify the best therapeutic choices for treating patients with advanced, refractory, or inflammatory breast cancer.

To read more:  TheraLink® Assay Expansion for Breast Cancer